Press Releases

Monod Bio Receives $1.5M Grant to Develop NovoBodies™ for  Next-Generation Tuberculosis Diagnostics

Read More

Monod Bio Launches CRP Biosensor on New NovoLISA Platform

Read More

Monod Bio Launches World’s First Fully De Novo Protein Product: Luciferase LuxSit™ Pro for Life Sciences Research and Diagnostics

Read More